Jerad G. Seurer - 30 Apr 2024 Form 3 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Role
Gen. Counsel & Corp. Secretary
Signature
/s/ Jerad G. Seurer
Issuer symbol
AVDL
Transactions as of
30 Apr 2024
Net transactions value
$0
Form type
3
Filing time
03 May 2024, 16:30:05 UTC
Next filing
07 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AVDL Ordinary Shares 8,795 30 Apr 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AVDL Stock Option (Right to Buy) 30 Apr 2024 Ordinary Shares 25,000 $9.67 Direct F1
holding AVDL Stock Option (Right to Buy) 30 Apr 2024 Ordinary Shares 30,000 $7.55 Direct F1
holding AVDL Stock Option (Right to Buy) 30 Apr 2024 Ordinary Shares 80,000 $6.79 Direct F2
holding AVDL Stock Option (Right to Buy) 30 Apr 2024 Ordinary Shares 47,500 $8.20 Direct F3
holding AVDL Stock Option (Right to Buy) 30 Apr 2024 Ordinary Shares 100,000 $4.69 Direct F4
holding AVDL Stock Option (Right to Buy) 30 Apr 2024 Ordinary Shares 125,000 $13.57 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options fully vested and exercisable.
F2 Options become exercisable as to 20,000 ordinary shares on each of the first four anniversaries after the 12/8/2020 grant date.
F3 Options become exercisable as to 11,875 ordinary shares on each of the first four anniversaries after the 12/7/2021 grant date.
F4 Options become exercisable as to 50,000 ordinary shares on each of 6/1/2023 and 6/1/2024.
F5 Options become exercisable as to 31,250 ordinary shares on each of the first four anniversaries after the 2/20/2024 grant date.

Remarks:

Exhibit 24 - Power of Attorney